Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
TE ›
TERPACAN
Trademark search for:
TERPACAN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-01-21 — Application filed
2020-01-24 — Application filed
2020-01-25 — Application filed
2020-04-08 — Final disposition recorded
2020-04-08 — Final disposition recorded
2020-04-08 — Assigned to examiner
2020-04-08 — Final disposition recorded
2020-10-06 — Office action issued
2021-01-19 — Assigned to lie
2021-01-22 — Teas/email correspondence entered
2021-01-22 — Correspondence received in law office
2021-02-12 — Suspension letter written
2021-02-12 — Letter of suspension e-mailed
2021-02-12 — Notification of letter of suspension e-mailed
2021-09-15 — Suspension checked - to attorney for action
2021-10-08 — Suspension letter written
2021-10-08 — Letter of suspension e-mailed
2021-10-08 — Notification of letter of suspension e-mailed
2022-05-20 — Suspension checked - to attorney for action
2022-06-13 — Suspension checked - to attorney for action
2022-07-05 — Suspension checked - to attorney for action
2022-08-01 — Suspension inquiry written
2022-08-01 — Inquiry to suspension e-mailed
2022-08-01 — Notification of inquiry as to suspension e-mailed
2023-02-01 — Teas response to suspension inquiry received
2023-02-08 — Assigned to lie
2023-02-09 — Teas/email correspondence entered
2023-02-09 — Correspondence received in law office
2023-02-21 — Examiners amendment -written
2023-02-21 — Approved for pub - principal register
2023-02-21 — Examiners amendment e-mailed
2023-02-21 — Notification of examiners amendment e-mailed
2023-02-21 — Examiner's amendment entered
2023-03-08 — Notification of notice of publication e-mailed
2023-03-28 — Published for opposition
2023-03-28 — Official gazette publication confirmation e-mailed
2023-05-02 — Assigned to examiner
2023-05-23 — Noa e-mailed - sou required from applicant
2023-12-25 — Application abandoned
2023-12-25 — Final status recorded
2023-12-26 — Application abandoned
Owner Information
TETRA BIO-PHARMA INC.
Longueuil, Quebec CA
TETRA BIO-PHARMA INC.
Longueuil, Quebec CA
Correspondent
Shamus T. O'Doherty RANDALL | DANSKIN PS 601 W. RIVERSIDE SUITE 1500 SPOKANE, WA 99201
Filing Details
Filing Date:
2020-01-21
Status Date:
2023-12-25
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.